Doctor of Osteopathy Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Jonathan Stahl

Surgery Houston, TX Doctor of Osteopathy

NPI 1235511015 CMS profile 8806823

6560 Fannin St Ste 1404, Houston, TX 77030

Open in the dashboard

General payments

$104,560

169 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jonathan Stahl of Houston, TX is reported in the CMS Open Payments database as having received $104,560 across 169 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $82,487 91
2024 General $20,805 66
2023 General $952 8
2022 General $205 2
2021 General $22 1
2020 General $88 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Stahl
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Jonathan Stahl were reported at $82,487. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Jonathan Stahl Surgery median Middle half National median
2019 $0 $253 $82–$1,521 $163
2020 $88 $131 $40–$706 $114
2021 $22 $168 $50–$904 $132
2022 $205 $224 $76–$1,218 $149
2023 $952 $253 $82–$1,255 $160
2024 $20,805 $279 $90–$1,381 $164
2025 $82,487 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Kerecis Limited $59,823 50 payments
  2. Intuitive Surgical, Inc. $36,441 56 payments
  3. Zimmer Biomet Holdings, Inc. $2,597 16 payments
  4. TELA Bio, Inc. $2,407 8 payments
  5. Davol Inc. $1,657 13 payments
  6. Baxter Healthcare $387 6 payments
  7. Smith+Nephew, Inc. $274 8 payments
  8. Atricure, Inc. $254 2 payments
  9. LeMaitre Vascular, Inc. $144 1 payment
  10. CSL Behring $125 1 payment
  11. Other $451 8 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $42,415 15 payments
  2. Education $31,220 9 payments
  3. Travel and Lodging $21,224 46 payments
  4. Food and Beverage $8,192 95 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,500 3 payments
  6. Gift $9 1 payment
Products named General payments · program years 2020–2025
  1. Kerecis SurgiClose Wound Care $49,646 41 payments
  2. Kerecis GraftGuide $49,646 41 payments
  3. Kerecis SurgiClose Wound Care $49,646 41 payments
  4. Kerecis SurgiClose Wound Care $49,646 41 payments
  5. Kerecis SurgiClose Wound Care $49,646 41 payments
  6. Da Vinci Surgical System $36,441 56 payments
  7. Kerecis Omega3 SurgiClose $10,177 9 payments
  8. Kerecis Omega3 Marigen Wound Care $10,164 8 payments
  9. Kerecis Omega3 Marigen Wound Care $9,778 7 payments
  10. Kerecis Omega3 Marigen Wound Care $9,778 7 payments
  11. Other $18,220 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 97 billing codes

Paid by Medicare

$109,262

Medicare's payments for the services billed

Medicare patients

357

Average age 76

Services billed

1,110

191 women, 166 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 59%
Chronic kidney disease 46%
Diabetes 44%
Heart failure 42%
Ischemic heart disease 39%
Atrial fibrillation 39%
Depression 39%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Kcentra
  • CSL Behring $125
$125 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

169 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record